Annals of the Academy of Medicine, Singapore最新文献

筛选
英文 中文
Real-world data on the use of emicizumab in patients with haemophilia A with and without inhibitors in Singapore. 关于在新加坡使用埃米珠单抗治疗伴有或未伴有抑制剂的 A 型血友病患者的实际数据。
IF 2.5
Annals of the Academy of Medicine, Singapore Pub Date : 2023-11-29 DOI: 10.47102/annals-acadmedsg.2023100
Ming Wei Lee, May Anne Cheong, Heng Joo Ng, Sim Leng Tien, Joyce Ching Mei Lam
{"title":"Real-world data on the use of emicizumab in patients with haemophilia A with and without inhibitors in Singapore.","authors":"Ming Wei Lee, May Anne Cheong, Heng Joo Ng, Sim Leng Tien, Joyce Ching Mei Lam","doi":"10.47102/annals-acadmedsg.2023100","DOIUrl":"10.47102/annals-acadmedsg.2023100","url":null,"abstract":"<p><strong>Introduction: </strong>Emicizumab is a bispecific monoclonal antibody that mimics the function of factor VIII by binding to factor IXa and factor X to achieve haemostasis in haemophilia A. The long half-life and subcutaneous mode of administration makes emicizumab a compelling treatment option for bleeding prophylaxis. There is still limited real-world data on its use and management considerations, especially during surgical procedures. The objective of the study is to describe the real-world experience of emicizumab in a cohort of adult and paediatric haemophilia A patients in Singapore, including its use in the periprocedural setting.</p><p><strong>Method: </strong>This was an observational study conducted at the 2 main haemophilia treatment centres in Singapore. All haemophilia A patients who commenced treatment with emicizumab before 1 July 2022 were recruited.</p><p><strong>Results: </strong>A total of 18 patients with haemophilia A were included in this study. Ten (55.6%) patients had active inhibitors. The median annual bleeding rate for all patients before emicizumab use was 4.5 events (interquartile range [IQR] 2.8-8.3) compared with 0 events (IQR 0-0) after emicizumab was commenced (P=0). There were no adverse events of venous or arterial thrombosis, thrombotic microangiopathy, or death. A total of 6 procedures in 5 patients were performed during the study period with no major bleeding complications.</p><p><strong>Conclusion: </strong>Emicizumab effectively protects against bleeding in haemophilia A patients with and without inhibitors, including in children less than 12 years old. More studies are required to address clinical nuances, such as periprocedural management and the role of immune tolerance in patients with inhibitors on emicizumab.</p>","PeriodicalId":502093,"journal":{"name":"Annals of the Academy of Medicine, Singapore","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141452649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Value the patient as a person: Answering the call for a person-centred model of care. 重视病人的人格:响应以人为本的护理模式的号召。
IF 2.5
Annals of the Academy of Medicine, Singapore Pub Date : 2023-11-29 DOI: 10.47102/annals-acadmedsg.2023188
Wei Zhen Hong, Jason Phua
{"title":"Value the patient as a person: Answering the call for a person-centred model of care.","authors":"Wei Zhen Hong, Jason Phua","doi":"10.47102/annals-acadmedsg.2023188","DOIUrl":"10.47102/annals-acadmedsg.2023188","url":null,"abstract":"","PeriodicalId":502093,"journal":{"name":"Annals of the Academy of Medicine, Singapore","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141452668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and management. AL 淀粉样变性:新加坡骨髓瘤研究小组关于诊断、治疗和管理的共识指南。
IF 2.5
Annals of the Academy of Medicine, Singapore Pub Date : 2023-11-29 DOI: 10.47102/annals-acadmedsg.2023101
Melinda Tan, Yunxin Chen, Melissa Ooi, Sanjay de Mel, Daryl Tan, Cinnie Soekojo, Allison Tso, Chun Yuan Khoo, Hui Zhuan Tan, Jason Choo, Lian King Lee, Colin Phipps Diong, Yeow Tee Goh, William Hwang, Yeh Ching Linn, Aloysius Ho, Wee Joo Chng, Chandramouli Nagarajan
{"title":"AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and management.","authors":"Melinda Tan, Yunxin Chen, Melissa Ooi, Sanjay de Mel, Daryl Tan, Cinnie Soekojo, Allison Tso, Chun Yuan Khoo, Hui Zhuan Tan, Jason Choo, Lian King Lee, Colin Phipps Diong, Yeow Tee Goh, William Hwang, Yeh Ching Linn, Aloysius Ho, Wee Joo Chng, Chandramouli Nagarajan","doi":"10.47102/annals-acadmedsg.2023101","DOIUrl":"10.47102/annals-acadmedsg.2023101","url":null,"abstract":"<p><p>AL amyloidosis is the most common form of systemic amyloidosis. However, the non-specific nature of presenting symptoms requires the need for a heightened clinical suspicion to detect unexplained manifestations in the appropriate clinical setting. Early detection and treatment are crucial as the degree of cardiac involvement emerges as a primary prognostic predictor of survival in a patient with AL amyloidosis. Following the diagnosis of AL amyloidosis with appropriate tissue biopsies, prompt treatment with a bortezomib, cyclophosphamide and dexamethasone-based first-line induction with or without daratumumab should be initiated. The goal of treatment is to achieve the best haematologic response possible, ideally with involved free light chain <20 mg/L, as it offers the best chance of organ function improvement. Treatment should be changed if patients do not achieve a partial response within 2 cycles of treatment or very good partial response after 4 cycles or after autologous stem cell transplant, as achievement of profound and prolonged clonal responses translates to better organ response and long-term outcomes. Early involvement of multidisciplinary subspecialists such as renal physicians, cardiologists, neurologists, and gastroenterologists for optimal maintenance and support of involved organs is recommended for optimal management of patients with AL amyloidosis.</p>","PeriodicalId":502093,"journal":{"name":"Annals of the Academy of Medicine, Singapore","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141452642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paradigm shifts in haemophilia A therapy with emicizumab prophylaxis in Asia. 亚洲使用埃米珠单抗预防性治疗 A 型血友病的范式转变。
IF 2.5
Annals of the Academy of Medicine, Singapore Pub Date : 2023-11-29 DOI: 10.47102/annals-acadmedsg.2023308
Darintr Sosothikul, Chatphatai Moonla
{"title":"Paradigm shifts in haemophilia A therapy with emicizumab prophylaxis in Asia.","authors":"Darintr Sosothikul, Chatphatai Moonla","doi":"10.47102/annals-acadmedsg.2023308","DOIUrl":"https://doi.org/10.47102/annals-acadmedsg.2023308","url":null,"abstract":"","PeriodicalId":502093,"journal":{"name":"Annals of the Academy of Medicine, Singapore","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141452648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of a targeted congenital cytomegalovirus infection screening approach among infants born ≥35 weeks gestation. 在妊娠≥35 周的新生儿中开展有针对性的先天性巨细胞病毒感染筛查的结果。
IF 2.5
Annals of the Academy of Medicine, Singapore Pub Date : 2023-11-29 DOI: 10.47102/annals-acadmedsg.2023254
Yee Yin Tan, Ching Yee Chan, Kavitha Sothirasan, Pih Lin Tan, Matthias Maiwald, Koh Cheng Thoon, Kee Thai Yeo
{"title":"Outcomes of a targeted congenital cytomegalovirus infection screening approach among infants born ≥35 weeks gestation.","authors":"Yee Yin Tan, Ching Yee Chan, Kavitha Sothirasan, Pih Lin Tan, Matthias Maiwald, Koh Cheng Thoon, Kee Thai Yeo","doi":"10.47102/annals-acadmedsg.2023254","DOIUrl":"https://doi.org/10.47102/annals-acadmedsg.2023254","url":null,"abstract":"","PeriodicalId":502093,"journal":{"name":"Annals of the Academy of Medicine, Singapore","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141452647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Burden of antibiotic resistance in infections among very-low-birthweight infants in Singapore. 新加坡极低出生体重儿感染抗生素耐药性的负担。
IF 2.5
Annals of the Academy of Medicine, Singapore Pub Date : 2023-11-29 DOI: 10.47102/annals-acadmedsg.2023190
Nadira Shahrul Baharin, Menghao Duan, Marcus Wing Choy Loe, Guan Lin Goh, Koh Cheng Thoon, Victor Samuel Rajadurai, Kee Thai Yeo
{"title":"Burden of antibiotic resistance in infections among very-low-birthweight infants in Singapore.","authors":"Nadira Shahrul Baharin, Menghao Duan, Marcus Wing Choy Loe, Guan Lin Goh, Koh Cheng Thoon, Victor Samuel Rajadurai, Kee Thai Yeo","doi":"10.47102/annals-acadmedsg.2023190","DOIUrl":"https://doi.org/10.47102/annals-acadmedsg.2023190","url":null,"abstract":"<p><strong>Introduction: </strong>Recent reports have described the increasing predominance of Gram-negative organisms among invasive bacterial infections affecting preterm infants. This changing pattern of infections is concerning due to the spread of antibiotic resistance among Gram-negatives.</p><p><strong>Method: </strong>We conducted a single-centre, retrospective cohort study involving very-low-birthweight (VLBW) (<1500 grams) infants born <32 weeks gestation, with culture-proven infections (blood, urine, cerebrospinal fluid [CSF]) in the neonatal intensive care unit from 1 January 2005 to 31 October 2017.</p><p><strong>Results: </strong>A total of 278 out of 2431 (11.4%) VLBW infants born <32 weeks gestation developed 334 infections, i.e. 52 (15.6%) early-onset infections (EOIs) and 282 (84.4%) late-onset infections (LOIs). The overall incidence decreased from 247 to 68 infections per 1000 infants over the study period, corresponding to reductions in LOI (211 to 62 infections per 1000 infants). A total of 378 bacteria were isolated, i.e. Gram-negatives accounted for 70.9% (45 of 59 [76.3%] EOI; 223 of 319 [69.9%] LOI). Specific resistant organisms were noted, i.e. Methicillin-resistant Staphylococcus aureus (8 of 21 S. aureus infections [38.1%]); Cephalosporin-resistant Klebsiella (18 of 62 isolates [29.0%]) and multidrug-resistant [MDR] Acinetobacter (10 of 27 isolates [37.0%]). MDR organisms accounted for 85 of 195 (43.6%) Gram-negative infections from the bloodstream and CSF. Based on laboratory susceptibility testing, only 63.5% and 49.3% of infecting bacteria isolated in blood were susceptible to empiric antibiotic regimens used for suspected EOI and LOI, respectively.</p><p><strong>Conclusion: </strong>Gram-negative bacteria are the predominant causative organisms for EOI and LOI and are frequently MDR. Understanding the pattern of antimicrobial resistance is important in providing appropriate empiric coverage for neonatal infections.</p>","PeriodicalId":502093,"journal":{"name":"Annals of the Academy of Medicine, Singapore","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141452643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The practice patterns and perceptions of surgeons in Singapore regarding breast-conserving surgery. 新加坡外科医生对保乳手术的实践模式和看法。
IF 2.5
Annals of the Academy of Medicine, Singapore Pub Date : 2023-11-29 DOI: 10.47102/annals-acadmedsg.2023111
Sabrina Ngaserin, Clarice Biru Yeo, Faith Qi-Hui Leong, Veronique Kiak Mien Tan, Geok Hoon Lim, Su-Ming Tan, Benita Kiat-Tee Tan
{"title":"The practice patterns and perceptions of surgeons in Singapore regarding breast-conserving surgery.","authors":"Sabrina Ngaserin, Clarice Biru Yeo, Faith Qi-Hui Leong, Veronique Kiak Mien Tan, Geok Hoon Lim, Su-Ming Tan, Benita Kiat-Tee Tan","doi":"10.47102/annals-acadmedsg.2023111","DOIUrl":"https://doi.org/10.47102/annals-acadmedsg.2023111","url":null,"abstract":"","PeriodicalId":502093,"journal":{"name":"Annals of the Academy of Medicine, Singapore","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141452667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thiazide diuretics in chronic kidney disease: Is there still a role? 慢性肾脏病中的噻嗪类利尿剂:还有作用吗?
IF 2.5
Annals of the Academy of Medicine, Singapore Pub Date : 2023-10-30 DOI: 10.47102/annals-acadmedsg.2023224
Sabrina Haroon, Matthew Edward Cove
{"title":"Thiazide diuretics in chronic kidney disease: Is there still a role?","authors":"Sabrina Haroon, Matthew Edward Cove","doi":"10.47102/annals-acadmedsg.2023224","DOIUrl":"https://doi.org/10.47102/annals-acadmedsg.2023224","url":null,"abstract":"","PeriodicalId":502093,"journal":{"name":"Annals of the Academy of Medicine, Singapore","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141452640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19: The virus, vaccine and paediatric heart. COVID-19:病毒、疫苗和小儿心脏。
IF 2.5
Annals of the Academy of Medicine, Singapore Pub Date : 2023-10-30 DOI: 10.47102/annals-acadmedsg.2023335
Jonathan Tze Liang Choo
{"title":"COVID-19: The virus, vaccine and paediatric heart.","authors":"Jonathan Tze Liang Choo","doi":"10.47102/annals-acadmedsg.2023335","DOIUrl":"https://doi.org/10.47102/annals-acadmedsg.2023335","url":null,"abstract":"","PeriodicalId":502093,"journal":{"name":"Annals of the Academy of Medicine, Singapore","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141452581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world data to measure and improve quality of asthma care. 用真实世界的数据来衡量和改善哮喘护理的质量。
IF 2.5
Annals of the Academy of Medicine, Singapore Pub Date : 2023-10-30 DOI: 10.47102/annals-acadmedsg.2023349
Wern Ee Tang, John Abisheganaden
{"title":"Real-world data to measure and improve quality of asthma care.","authors":"Wern Ee Tang, John Abisheganaden","doi":"10.47102/annals-acadmedsg.2023349","DOIUrl":"https://doi.org/10.47102/annals-acadmedsg.2023349","url":null,"abstract":"","PeriodicalId":502093,"journal":{"name":"Annals of the Academy of Medicine, Singapore","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141452637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信